▲ Peaking
Business
🔮 holds
Scribe Therapeutics files for IPO in test of public appetite for earlier-stage biotechs
Scribe Therapeutics files for $75 million IPO to test public appetite for early-stage biotechs
Scribe Therapeutics Stockholders Include Eli Lilly
1 news trends Newsylist has tracked involving Scribe Therapeutics Stockholders Include Eli Lilly — newest first.